Skip to main content

Zilbrysq Side Effects

Generic name: zilucoplan

Medically reviewed by Drugs.com. Last updated on Dec 10, 2024.

Note: This document provides detailed information about Zilbrysq Side Effects associated with zilucoplan. Some dosage forms listed on this page may not apply specifically to the brand name Zilbrysq.

Applies to zilucoplan: parenteral injection for sub-q use.

Important warnings This medicine can cause some serious health issues

REMS:

FDA approved a REMS for zilucoplan to ensure that the benefits outweigh the risks.

The REMS may apply to one or more preparations of zilucoplan and consists of the following: elements to assure safe use and implementation system.

See the FDA REMS page ([Web]) for specific information.

Side effects include:

Most common adverse effects (≥10%): injection site reactions, upper respiratory tract infection, diarrhea.

For healthcare professionals

Applies to zilucoplan: subcutaneous solution.

General adverse events

The most common adverse effects in at least 10% of patients were injection site reactions, upper respiratory tract infections, and diarrhea.[Ref]

Gastrointestinal

Pancreatic events included pancreatitis and pancreatic cysts.[Ref]

Genitourinary

Local

Other

Respiratory

References

1. (2023) "Product Information. Zilbrysq (zilucoplan)." UCB Pharma Inc

Further information

Zilbrysq side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.